Re: Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: A modeling analysis

被引：0
|
作者：
Gurwitz, David [1 ]
Newman, William [2 ]
机构：
[1] Tel Aviv Univ, Dept Human Mol Genet & Biochem, Sackler Fac Med, IL-69978 Tel Aviv, Israel
[2] Univ Manchester, Dept Med Genet, Manchester M13 9PL, Lancs, England
来源：
JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2008年 / 100卷 / 18期
关键词：
D O I：
10.1093/jnci/djn269
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] CYP2D6 genotype affects outcome in postmenopausal breast cancer patients treated with tamoxifen monotherapy
    AM Thompson
    S Bray
    AM Johnson
    P Quinlan
    DM Nikloff
    DG Evans
    R Clarke
    HJ Lawrence
    A Howell
    A Latif
    R Ferraldeschl
    G Hillman
    M Fontecha
    WG Newman
    Breast Cancer Research, 12
  • [42] CYP2D6 and tamoxifen: DNA matters in breast cancer
    Janelle M. Hoskins
    Lisa A. Carey
    Howard L. McLeod
    Nature Reviews Cancer, 2009, 9 : 576 - 586
  • [43] CYP2D6 and tamoxifen: DNA matters in breast cancer
    Hoskins, Janelle M.
    Carey, Lisa A.
    Mcleod, Howard L.
    NATURE REVIEWS CANCER, 2009, 9 (08) : 576 - 586
  • [44] CYP2D6 tamoxifen: Pharmacogenetics in early breast cancer
    Brauch H.
    Schroth W.
    Der Gynäkologe, 2010, 43 (7): : 579 - 585
  • [45] Prevalence of CYP2D6*2, CYP2D6*4, CYP2D6*10, and CYP3A5*3 in Thai breast cancer patients undergoing tamoxifen treatment
    Charoenchokthavee, Wanaporn
    Panomvana, Duangchit
    Sriuranpong, Virote
    Areepium, Nutthada
    BREAST CANCER-TARGETS AND THERAPY, 2016, 8 : 149 - 155
  • [46] CYP2D6 genotype and optimization of breast cancer treatment
    Bandres, F.
    Chicharro, L. M.
    Tejerina, A.
    del Saz, M.
    Fernaacutendez-Santander, A.
    EJC SUPPLEMENTS, 2010, 8 (03): : 179 - 179
  • [47] Effect of CYP2D6 polymorphisms on breast cancer recurrence
    Morrow, Phuong K.
    Serna, Ruben
    Broglio, Kristine
    Pusztai, Lajos
    Nikoloff, D. Michelle
    Hillman, Grantland R.
    Fontecha, Marcel
    Li, Rui
    Michaud, Laura
    Hortobagyi, Gabriel
    Gonzalez-Angulo, Ana M.
    CANCER, 2012, 118 (05) : 1221 - 1227
  • [48] Pharmacogenomics of breast cancer: highlighting CYP2D6 and tamoxifen
    Chan, Carmen W. H.
    Law, Bernard M. H.
    So, Winnie K. W.
    Chow, Ka Ming
    Waye, Mary M. Y.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (06) : 1395 - 1404
  • [49] Pharmacogenomics of breast cancer: highlighting CYP2D6 and tamoxifen
    Carmen W. H. Chan
    Bernard M. H. Law
    Winnie K. W. So
    Ka Ming Chow
    Mary M. Y. Waye
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 1395 - 1404
  • [50] Significant Effect of Polymorphisms in CYP2D6 and ABCC2 on Clinical Outcomes of Adjuvant Tamoxifen Therapy for Breast Cancer Patients
    Kiyotani, Kazuma
    Mushiroda, Taisei
    Imamura, Chiyo K.
    Hosono, Naoya
    Tsunoda, Tatsuhiko
    Kubo, Michiaki
    Tanigawara, Yusuke
    Flockhart, David A.
    Desta, Zeruesenay
    Skaar, Todd C.
    Aki, Fuminori
    Hirata, Koichi
    Takatsuka, Yuichi
    Okazaki, Minoru
    Ohsumi, Shozo
    Yamakawa, Takashi
    Sasa, Mitsunori
    Nakamura, Yusuke
    Zembutsu, Hitoshi
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (08) : 1287 - 1293
12345